TOXYS
Toxys is a Dutch biotech company that provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during the early phases of product and drug development. We aim to bring information to our customers that is essential to make informed decisions on which compounds to progress in the drug/compound development pipeline, thereby contributing to the development of better medicines and products and to reduce animal testing.
TOXYS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2014-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.toxys.com
Total Employee:
1+
Status:
Active
Contact:
+31 71 3322470
Email Addresses:
[email protected]
Total Funding:
2.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Mobile Non Scaleable Content IPv6 JsDelivr Person Schema
Similar Organizations
![]()
Geneius
Geneius is a Biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
Neomorph
Neomorph is a biotechnology company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
![]()
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
![]()
CareDx
CareDx is a novel molยญeยญcยญuยญlar diagnosยญtics comยญpany.
Current Employees Featured
![]()
Founder
![]()
Investors List
![]()
Rabobank
Rabobank investment in Venture Round - Toxys
KIKK Capital
KIKK Capital investment in Venture Round - Toxys
![]()
InnovationQuarter
InnovationQuarter investment in Venture Round - Toxys
![]()
InnovationQuarter
InnovationQuarter investment in Series A - Toxys
![]()
Zeeuws Investerings Fonds
Zeeuws Investerings Fonds investment in Series A - Toxys
Key Employee Changes
| Date | New article |
|---|---|
| 2021-02-24 | Toxys Strengthens Executive Team with Appointment of a CSO |
| 2020-01-21 | Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions |
Official Site Inspections
http://www.toxys.com
- Host name: 183.145.214.35.bc.googleusercontent.com
- IP address: 35.214.145.183
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "Toxys"
About us - Toxys
Toxys is a global leading expert that develops and offers a broad spectrum of unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. We are experts in the fields of genotoxicity, โฆSee details»
The company - Toxys
Toxys is a Dutch biotech company that provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during โฆSee details»
Toxys - Crunchbase Company Profile & Funding
Organization. Toxys . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Toxys is a Dutch biotech company. Leiden, Zuid-Holland, The Netherlands; 1-10; ... Toxys โฆSee details»
Toxys - LinkedIn
Toxys is global leading expert that develops and offers a broad spectrum of unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food.See details»
Toxys Company Profile: Valuation, Funding & Investors 2024
Who is the CEO of Toxys? Giel Hendriks Ph.D is the CEO of Toxys. Where is Toxys headquartered? Toxys is headquartered in Oegstgeest, Netherlands. What is the size of โฆSee details»
Toxys Company Profile - Office Locations, Competitors, Revenue
Toxys is a biotech company that offers in vitro solutions with expertise in genotoxicity, developmental, and mechanistic toxicity screening. Its ToxTracker product is a throughput โฆSee details»
Toxys - VentureRadar
Toxys provides next-generation genotoxicity testing services to rapidly identify potential carcinogenic properties of novel compounds during the early phases of product and drug โฆSee details»
Toxys - Products, Competitors, Financials, Employees, โฆ
Toxys is a Dutch biotech company specializing in innovative in vitro toxicity screening solutions within the biotechnology and pharmaceutical sectors. Use the CB Insights Platform to explore โฆSee details»
ToxProfiler - Toxys
He co-developed the HepG2 BAC-GFP reporter platform that is central to ToxProfiler. Bas joined Toxys in 2020 as a senior scientist to run ToxProfiler and further expand the assay with his knowledge in compound-induced stress โฆSee details»
Toxys - Scientist.com
Toxys exclusively offers the ToxTracker assay, our state-of-the-art stem cell-based reporter assay that provides mechanistic insights into the genotoxic properties of pharmaceutical compounds โฆSee details»
IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In โฆ
Mar 9, 2023 Toxys is providing IIVS with the materials and training needed to achieve proficiency and expertise in applying this technology as a service. With an anticipated โฆSee details»
Toxys โ KIKK CAPITAL
Toxys is a specialized Contract Research Organization (CRO) which focusses on the development and execution of mechanistic in vitro toxicity tests. Toxys uses its unique โฆSee details»
Toxys Opens US Office and Production Facility to Accelerate Growth
Mar 16, 2022 Toxys is an expert in toxicological research with a mission to improve animal-free safety testing by creating mechanistic in vitro chemical safety tests to meet the needs for safer โฆSee details»
Labstat Inc., A Certified Group Company, Partners With Toxys
Mar 15, 2023 Toxys has been working with global Pharma companies, the major chemical, cosmetics and food multinationals and is highly valued for its scientific expertise, high-quality โฆSee details»
ToxTracker - In vitro assay for genotoxicity testing
Toxys offers the ToxTracker® assay, our state-of-the-art stem cell-based reporter assay that provides mechanistic insights into the mode-of-action (MOA) of genotoxic properties of โฆSee details»
Toxys Reports Positive Results From the OECD Ring Trial โฆ
Apr 24, 2024 Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©. ToxTracker is an in vitro method that โฆSee details»
Services & Products - Toxys
Toxys offers a selection of predictive toxicology services and products to reliably assess the safety of compounds from early screening up to regulatory applications. Our unique โฆSee details»
Toxys
This website relies on running JavaScript. If you disabled this in your settings, please turn this on. If your browser does not run JavaScript, please consider using ...See details»
News - Toxys
Our Poster Presentations The ToxTracker reporter system is a mechanistic genotoxicity platform that discriminates clastogenic from aneugenic compounds.Giel Hendriks1, Remco Derr1, โฆSee details»